Focus Partners Advisor Solutions LLC acquired a new position in shares of Teleflex Incorporated (NYSE:TFX – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 12,178 shares of the medical technology company’s stock, valued at approximately $1,362,000.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Journey Strategic Wealth LLC bought a new stake in shares of Teleflex in the third quarter worth about $341,000. Royce & Associates LP acquired a new position in shares of Teleflex in the 3rd quarter valued at approximately $8,565,000. Handelsbanken Fonder AB increased its stake in Teleflex by 35.8% during the 3rd quarter. Handelsbanken Fonder AB now owns 16,700 shares of the medical technology company’s stock worth $2,043,000 after purchasing an additional 4,400 shares in the last quarter. Choreo LLC acquired a new stake in Teleflex during the 3rd quarter worth approximately $320,000. Finally, MAI Capital Management raised its holdings in Teleflex by 2,544.2% during the 3rd quarter. MAI Capital Management now owns 2,036 shares of the medical technology company’s stock worth $249,000 after buying an additional 1,959 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several equities research analysts have recently issued reports on TFX shares. Wall Street Zen downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Truist Financial upped their target price on shares of Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a research note on Thursday, December 18th. Wells Fargo & Company increased their target price on Teleflex from $116.00 to $130.00 and gave the stock an “equal weight” rating in a report on Friday, February 27th. Zacks Research lowered Teleflex from a “hold” rating to a “strong sell” rating in a report on Monday. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research report on Monday, December 29th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $140.83.
Teleflex Trading Down 1.4%
Shares of NYSE:TFX opened at $117.47 on Friday. The company’s 50-day moving average price is $111.15 and its two-hundred day moving average price is $118.70. Teleflex Incorporated has a one year low of $100.18 and a one year high of $143.32. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.54 and a quick ratio of 2.01. The stock has a market capitalization of $5.19 billion, a PE ratio of -5.72, a price-to-earnings-growth ratio of 0.77 and a beta of 0.87.
Teleflex (NYSE:TFX – Get Free Report) last released its earnings results on Thursday, February 26th. The medical technology company reported $1.93 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.73 by ($1.80). Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The company had revenue of $569.00 million during the quarter, compared to analyst estimates of $912.57 million. During the same period in the prior year, the firm posted $3.89 EPS. Teleflex’s revenue was down 28.5% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, equities analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.
Teleflex Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Friday, March 6th will be paid a dividend of $0.34 per share. The ex-dividend date is Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.2%. Teleflex’s dividend payout ratio is currently -6.62%.
About Teleflex
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Recommended Stories
- Five stocks we like better than Teleflex
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
